A group of US scientists at the University of California identified the cancer cell's absorption and survival glucose and a mechanism for extracting tumor growth.
At the same time, the content of a specific molecule allows the detection of a predictable condition that grows in cells, writes the online MedicalXpress editions.
Experts have found that it is important for the formation of new protein tumor formation that is used to treat diabetes mellitus type 2. According to the data, sodium glucose co-carrier 2 (SGLT2), responsible for the inclusion of glucose cells, is one of the major suppliers of cancer cells.
Cancer cells need glucose to survive and grow. That's why they need transport proteins from many glucose transporters.
Previous studies have shown that SGLT2 is very important for the development of certain types of cancers, including pancreatic and prostate cancer.
Using tomography for positron emission, the researchers have determined the activity of certain glucose carriers in different phases of development. Therefore, these cells had a large amount of SGLT2. Scientists say newly-created tumors provide carbohydrates mainly through SGLT2 and non-glucose transporters.
In the review of these data, researchers also found that SGLT2 growth can occur before the development of the tumor and is a good marker for early detection of the disease.
The discovery of American scientists can lead to preventative methods of cancer prevention.